Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-25-045429
Filing Date
2025-03-26
Accepted
2025-03-26 17:06:57
Documents
1
Period of Report
2025-03-18

Document Format Files

Seq Description Document Type Size
1 3/A ownership.html 3/A  
1 3/A ownership.xml 3/A 3136
  Complete submission text file 0000950170-25-045429.txt   4717
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39409 | Film No.: 25774205

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 650-249-2727
Kalaris Therapeutics, Inc. (Issuer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)